according to The Giant Company. Flu shots for the 2024-25 flu and cold season protect individuals against three strains of ...
The pharmaceutical giant is the first company to release Phase 3 clinical trial data on a combination flu-COVID vaccine, leading the industry over rivals such as Novavax and Pfizer. “Combination ...
The biopharmaceutical giant, along with its partner BioNTech ... We've just started our phase-three study of a quadrant flu vaccine made out of mRNA. We see it has several advantages over current ...